Rett syndrome: insights into genetic, molecular and circuit mechanisms
Rett syndrome (RTT) is a severe neurological disorder caused by mutations in the gene encoding methyl-CpG-binding protein 2 (MeCP2). Almost two decades of research into RTT have greatly advanced our understanding of the function and regulation of the multifunctional protein MeCP2. Here, we review re...
Main Authors: | Ip, Pak Kan, Mellios, Nikolaos, Sur, Mriganka |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2020
|
Online Access: | https://hdl.handle.net/1721.1/127274 |
Similar Items
-
Rett Syndrome: Genes, Synapses, Circuits, and Therapeutics
by: Banerjee, Abhishek, et al.
Published: (2016) -
Developmental Dynamics of Rett Syndrome
by: Banerjee, Abhishek, et al.
Published: (2016) -
Molecular Signatures of Response to Mecasermin in Children With Rett Syndrome
by: Shovlin, Stephen, et al.
Published: (2023) -
Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome
by: Garcia, Rodrigo, et al.
Published: (2015) -
β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome
by: Mellios, Nikolaos, et al.
Published: (2015)